Selección de lo mejor del año 2016 en el tratamiento de la hipertensión pulmonar

Gómez Sánchez, Miguel Ángel; Barrios Garrido-Lestache, Elvira.
Rev. esp. cardiol. (Ed. impr.) ; 70(4): 305-306, abr. 2017.
Artículo en Español | IBECS (España) | ID: ibc-161503

Documentos relacionados

  1. Post-trial access to investigational drugs in India: addressing challenges in the regulatory framework.
  2. Clinical Trials on Advanced Therapy Investigational Medicinal Products in Spain (2004-2022): Experience and Challenges for the Future.
  3. Regulatory issues and the potential use of Bayesian approaches for early drug approval systems in Japan.
  4. Assessing machine learning approaches for predicting failures of investigational drug candidates during clinical trials.
  5. When innovation outpaces regulations: The legal challenges for direct-to-patient supply of investigational medicinal products.
  6. Analysis and reporting of pediatric growth and development assessment from clinical trials: overview and challenges.
  7. Why children have to wait years for new drugs.
  8. Do Physicians Have a Duty to Discuss Expanded Access to Investigational Drugs with their Patients? A Normative Analysis.
  9. The Practice of Pharmaceutics and the Obligation to Expand Access to Investigational Drugs.
  10. Investigational antiviral drugs for the treatment of COVID-19 patients.